Leukopenia and neutropenia are similar blood conditions, but they are not exactly the same. Leukopenia is a low number of leukocytes (white blood cells), and neutropenia is a low number of neutrophils ...

Objective: To systematically evaluate the literature to determine whether vancomycin-induced neutropenia is dose- or duration-related and provide clinicians with feasible treatment alternatives.

For patients with hereditary hemorrhagic telangiectasia (HHT), pomalidomide yields a significant reduction in epistaxis ...

Seres Therapeutics' financial moves, potential drug developments, and investment appeal for speculative buyers in the biotech ...

With FDA approval for imetelstat and solid financials, Geron shows great promise in MDS treatment. Read more on GERN stock ...

The majority of secondary and prolonged infections were bacterial (56% and 49%, respectively) or viral (29% and 44%, respectively). Malignancy, congenital immunodeficiency, early and persistent ...

While infections pose a risk for morbidity and mortality among patients with MDS, more needs to be studied about the topic, ...

During a Case-Based Roundtable® event, Matthew A. Lunning, DO, discussed the updated trial data for 2 chimeric antigen ...

The FDA granted fast track designation to EO-3021 for the treatment of advanced or metastatic gastric and gastroesophageal ...

Oral and poster presentations of results from Study 501 evaluating lumateperone 42 mg as an adjunctive therapy to ...

The US FDA has approved Kisqali (ribociclib) for treating early-stage breast cancer in combination with hormone therapy. It ...